Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Real-world trends in the use of maintenance therapy in ovarian cancer across the United States from 2017 to 2021

Published:2024-11 Issue: Volume:190 Page:255-261
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Adjei Naomi N.,Haas Allen,Zhao Hui,Primm Kristin M.,Giordano Sharon H.,Sun Charlotte C.,Meyer Larissa A.

Funder

NCI

CPRIT

National Institutes of Health

University of Texas MD Anderson Cancer Center

Susan G Komen Breast Cancer Foundation

AstraZeneca

Publisher

Elsevier BV

Reference38 articles.

1. Current ovarian cancer maintenance strategies and promising new developments;Gogineni;J. Cancer,2021

2. Maintenance treatment of recurrent ovarian cancer: is it ready for prime time?;DiSilvestro;Cancer Treat. Rev.,2018

3. OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer;Aghajanian;J. Clin. Oncol.,2012

4. Incorporation of bevacizumab in the primary treatment of ovarian Cancer;Burger;N. Engl. J. Med.,2011

5. A phase 3 trial of bevacizumab in ovarian Cancer;Perren;N. Engl. J. Med.,2011

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP